Navigation Links
Indian And Danish Research Agencies To Work Together For Osteoporosis,,,,

India’s biotechnology company Avestha Gengraine Technologies (Avesthagen) has tied up //with Denmark's Centre for Clinical and Basic Research and Industrialisation Fund for Developing Countries (IFU) for osteoporosis research.

The collaboration is being done through the joint venture called Avesta Nordic Research Pvt. Ltd in which Avesthagen has invested 2.5 million euros and the Danish research organization had invested the same.

"The alliance will cover diagnosis, treatment and prevention of osteoporosis and related bone disorders," Avesthagen said in a statement Thursday.

Centre for Clinical and Basic Research, Denmark, is a private research institute that primarily works with conditions and diseases that arise in association with the menopause, especially osteoporosis.

IFU is an investment fund owned by the Danish government and has a directive to promote economic activities in developing countries like India by investing in commercial projects together with industry.

Commenting on the investment, Avesta Nordic chairman Helle Bechgaard said: "IFU had been keenly watching the rapid growth in the biotech sector globally, but more especially in India through our office in New Delhi over the past two years.

"We have made this strategic investment in Avesta Nordic because we believe in its platform and the huge potential of this sector."

Source: Indo-Asian News Service

Medindia on Osteoporosis- Further information

Osteoporosis: This is the disease that makes the bone brittle and is the cause of hip and other fractures that may lead to permanent disability, and at times even death. The spinal cord may start collapsing leading to a stooped posture, chronic pain etc. It is a condition that may arise due to a variety of factors like genetic, physiological, dietary and age. Osteoporosis is most common in women in their post menopause age , although all men above 50yrs are also at a risk from the condition.

For more information read:
http://www.medindia.net/patients/
patientinfo/osteoporosis.asp

'"/>




Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education Partners’ ... the field must first improve teacher preparation program design. It then asserts that ... that decades of input- and outcome-based research has failed to improve teacher education. ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s ... technology to directly address the resolution to globally reduce the harmful use of ... compound of FDA and TTB approved ingredients that when infused into alcohol, renders ...
(Date:3/28/2017)... WASHINGTON, DC (PRWEB) , ... March 28, 2017 ... ... call on elected representatives in state legislatures and Congress to protect parental rights ... the public health and safety in America. , The demonstration coincides with a ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of all holidays (IBT World Travel Trends Report). As travelers visit both urban ... range in temperatures, and prolonged sun exposure. In response, the outdoor industry has ...
(Date:3/28/2017)... ... 2017 , ... Via Oncology, the leading provider of oncology ... public-facing tool for analyzing the costs of various drug regimens in cancer care. ... patients, providers, insurers and pharmaceutical companies about the estimated costs of treatment options. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... DUBLIN , Mar 29, 2017 Research ... Global Market - Forecast to 2023" report to their offering. ... The ablation ... CAGR to reach $20,995.5 million by 2023. Ablation ... wide range of purposes, from cancerous or diseased tissue removal, to ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology: